Latest Insider Transactions at Nexalin Technology, Inc. (NXL)
This section provides a real-time view of insider transactions for Nexalin Technology, Inc. (NXL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nexalin Technology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nexalin Technology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
David Owens Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.34%
|
$1,000
$2.19 P/Share
|
|
Sep 30
2024
|
Ben Hu Director |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+33.94%
|
-
|
|
Sep 30
2024
|
Leslie Bernhard Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,838
+50.0%
|
-
|
|
Sep 23
2024
|
Marilyn Elson > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
700,000
+31.32%
|
-
|
|
Aug 13
2024
|
David Owens Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.67%
|
$0
$0.95 P/Share
|
|
Jun 28
2024
|
David Owens Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.68%
|
$1,000
$1.75 P/Share
|
|
Jun 18
2024
|
David Owens Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,619
+1.1%
|
$0
$0.71 P/Share
|
|
Jun 10
2024
|
David Owens Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+1.03%
|
$0
$0.64 P/Share
|
|
Sep 28
2022
|
Marilyn Elson > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,500
+1.12%
|
$9,500
$1.12 P/Share
|
|
Sep 16
2022
|
David Owens Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+1.74%
|
$10,000
$4.15 P/Share
|
|
Sep 16
2022
|
Mark White President/CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.86%
|
$10,000
$4.15 P/Share
|
|
Sep 16
2022
|
Rick Morad Director |
BUY
Open market or private purchase
|
Direct |
2,500
+2.26%
|
$10,000
$4.15 P/Share
|
|
Sep 16
2022
|
Alan Kazden Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+2.73%
|
$10,000
$4.15 P/Share
|
|
Sep 16
2022
|
Marilyn Elson > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
36,000
+4.18%
|
$144,000
$4.15 P/Share
|